Back to search
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Dolutegravir und Rilpivirin, ATC J05AR21
AOK Rheinland-Pfalz/Saarland - Die GesundheitskasseGermanyPublished on Jun 15, 2026
637 days left
GermanyDescription
Conclusion of non-exclusive rebate contracts pursuant to §§ 130a para. 8/130c para. 1 SGB V for medicinal products with the aforementioned active substance within the period from 01.08.2026 to 31.07.2028 with the possibility of concluding the contract at any time (open-house model). In the open house procedure, medicinal products according to the BfArM list pursuant to § 35 para. 5a SGB V (paediatric medicinal products) are excluded.
CPV codes
Pharmaceutical products
Documents & submission
AI summary
Sign in for an AI summaryContains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.
Related tenders
Germany – Personal care products – NEU_RV Hygieneverbrauchsmaterial und Reinigungsbedarf
Landeshauptstadt Dresden, GB Bildung, Jugend und Sport, Eigenbetrieb KindertageseinrichtungenGermanyPersonal care productsToilet paper, handkerchiefs, hand towels and serviettesCleaning productsDeadline in 6 daysPublished on Aug 31, 2026
Germany – Diagnostic systems – Rahmenvereinbarung über Reagenzienleasing für die Analytik mittels Schnell-PCR
Labor Berlin - Charité Vivantes GmbHGermanyDiagnostic systemsDiagnostic agentsLaboratory reagentsDeadline in 27 daysPublished on Aug 31, 2026
Germany – Beds for medical use – Klinikbetten mit Nachtschränken
LEG gGmbHGermanyBeds for medical useHospital bedsDeadline in 28 daysPublished on Aug 31, 2026
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V mit dem Wirkstoff ab dem 01.10.2026
GWQ ServicePlus AGGermanyPharmaceutical productsDeadline in 616 daysPublished on Aug 31, 2026